Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome - Watts, Gerald F.; Barrett, P. Hugh R.; Ji, Juying; Serone, Adrian P.; Chan, Dick C.; Croft, Kevin D.; Loehrer, Franziska; Johnson, Anthony G. (Diabetes (New York, N.Y.), 2003)
Keywords: Adult; Apolipoprotein A-I - blood; Apolipoprotein B-100; Apolipoproteins B - blood; Atorvastatin; Biological and medical sciences; Blood Glucose - analysis; Cholesterol - blood; Cholesterol, HDL - blood; Cholesterol, LDL - blood; Cross-Over Studies; Diet; Double-Blind Method; Fenofibrate - therapeutic use; Fundamental and applied biological sciences. Psychology; Heptanoic Acids - therapeutic use; Humans; Hypolipidemic Agents - therapeutic use; Insulin - blood; Insulin resistance; Kinetics; Lipoproteins - blood; Lipoproteins, HDL - blood; Lipoproteins, IDL; Lipoproteins, LDL - blood; Lipoproteins, VLDL - blood; Male; Metabolic Syndrome - blood; Metabolic Syndrome - drug therapy; Metabolic syndrome X; Middle Aged; Obesity - blood; Physiological aspects; Placebos; Pyrroles - therapeutic use; Triglycerides - blood; Australia